viernes, 6 de noviembre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 26, 2026

Downstream Processing Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) and Competitive Intelligence

View original at finance.yahoo.com
Downstream Processing Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) and Competitive Intelligence Company Logo The market is poised for growth (12.88% CAGR), driven by high demand for equipment due to capacity expansions, and the adoption of single-use systems, continuous bioprocessin…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Downstream purification market will surpass USD 14.75 billion in 2026 and potentially reach USD 27 billion by 2031

    80% confidence

  • Protein A resin consumes as much as 60% of downstream capital budgets

    80% confidence

  • Oversupply in capacity among some CDMOs has temporarily reduced utilization below 50%

    80% confidence

  • Cell disruption segment will grow at 14.88% CAGR, the fastest growing segment

    80% confidence

  • Filtration products market achieved USD 12.2 billion in 2026 and expected to reach USD 23.6 billion by 2031

    80% confidence

  • The downstream processing market will grow at a CAGR of 12.88% from 2026 to 2031

    80% confidence

  • Continuous bioprocessing reduces buffer consumption by up to 40%

    80% confidence

  • Asia-Pacific is the fastest growing region at a 14.35% CAGR

    80% confidence

  • North America secured 32.50% of the revenue share in 2025

    80% confidence

  • Capacity expansions worth over USD 50 billion occurred in 2024-2025

    80% confidence

  • Continuous manufacturing processes were implemented in 75% of new lines in North America

    80% confidence

  • Purification techniques accounted for 32.05% of downstream processing market revenue in 2025

    80% confidence

  • Filtration and membrane devices show the highest CAGR of 14.12%

    80% confidence

  • Chromatography columns and resins had a 35.10% revenue share in 2025

    80% confidence

  • The global downstream processing market will grow from USD 40.78 billion in 2025 to USD 84.25 billion by 2031

    80% confidence

  • Saudi Arabia plans to contribute USD 34.6 billion to non-oil GDP by 2040 through biomanufacturing

    80% confidence

  • Intensified multicolumn operations cut resin usage by 50% and boost output per square foot

    80% confidence

  • High-throughput resin screening kits cut development time by 30%

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,996
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,996 hechos verificados con la fuente5,552 documentos fuente archivados
Consulta estos datos → isubstrate.com
Downstream Processing Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) and Competitive Intelligence — Source | Via News | es.VIA.NEWS